| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 01/27/2009 | CA2361545C Purification of biological substances |
| 01/27/2009 | CA2225278C Recombinant mva virus, and the use thereof |
| 01/27/2009 | CA2135644C Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 01/25/2009 | CA2597865A1 Compositions for therapeutic treatment of hpv related conditions and diseases |
| 01/22/2009 | WO2009011413A1 Production and use of epitope-tagged hepatitis c virus particle |
| 01/22/2009 | WO2009010976A2 Compositions and methods for purifying and crystallizing molecules of interest |
| 01/22/2009 | WO2009009876A1 Influenza virus-like particles (vlps) comprising hemagglutinin produced within a plant |
| 01/22/2009 | WO2007126959A8 Methods and compositions for inducing an immune response to hiv and models for testing |
| 01/22/2009 | US20090023197 Method for purifying a viral suspension |
| 01/22/2009 | US20090023196 Stocks of replication-deficient adenovirus |
| 01/22/2009 | US20090022759 Adenovirus vector and method to manipulate the adenovirus genome |
| 01/22/2009 | US20090022748 Unique associated Kaposi's sarcoma virus sequences and uses thereof |
| 01/22/2009 | CA2729011A1 Varicella zoster virus-virus like particles (vlps) and antigens |
| 01/22/2009 | CA2696437A1 Production and use of epitope-tagged hepatitis c virus particle |
| 01/22/2009 | CA2693956A1 Influenza virus-like particles (vlps) comprising hemagglutinin produced within a plant |
| 01/21/2009 | EP2017333A1 Feline cell capable of being cultured without animal protein, and method for production of virus and method for production of vaccine using the feline cell |
| 01/21/2009 | EP2016174A2 Modified aav vectors having reduced capsid immunogenicity and use thereof |
| 01/21/2009 | EP2016173A2 Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments |
| 01/21/2009 | EP2015774A1 Influenza virus vaccine |
| 01/21/2009 | EP1487273B1 Compositions and methods for treatment of microbial infections |
| 01/21/2009 | EP1483375B1 A method for producing recombinant adenovirus viruses using site-specific recombination |
| 01/21/2009 | EP1261701B1 FULL-LENGTH INFECTIOUS cDNA CLONES OF TICK BORNE FLAVIVIRUS |
| 01/21/2009 | EP1105495B2 Method for producing yeast expressed hpv types 6 and 16 capsid proteins |
| 01/21/2009 | CN101351222A Mannose immunogens for HIV-1 |
| 01/21/2009 | CN101348798A Construction of recombinant adenovirus vector expressing bFGF protein and use of recombinant adenovirus vector for in vivo ear transfection |
| 01/21/2009 | CN101348780A Method of isolation and purification of trypsin from pronase protease and use thereof |
| 01/20/2009 | US7479554 AAV5 nucleic acids |
| 01/20/2009 | US7479553 Nucleic acids encoding mutant disulfide bond-stabilized human immunodeficiency virus type 1 (HIV-1) gp140 envelope glycoproteins |
| 01/20/2009 | US7479386 Hepatitis X virus for use in generation of antibody and vaccine compositions for use in diagnosis, prevention and treatment viral infection; immunotherapeutic and diagnostics |
| 01/20/2009 | US7479280 Papilloma virus capsid support comprising chimeric lymphocyte epitope for use in identifying modulators to treat and prevention cell proiferative, autoimmune and viral diseases |
| 01/15/2009 | WO2009009670A2 Apparatus and method for harvesting biologics from eggs |
| 01/15/2009 | WO2009008924A2 Methods of preventing and treating viral infections by inhibiting the deisgylation activity of otu domain-containing viral proteins |
| 01/15/2009 | WO2009008921A2 Influenza b viruses with reduced sensitivity to neuraminidase inhibitors |
| 01/15/2009 | WO2009007608A1 Method for purifying a viral suspension |
| 01/15/2009 | US20090017542 producing high titer, wild-type-free preparations of recombinant AAV (adeno-associated virus) virions; for use as tools in genetic engineering and gene therapy |
| 01/15/2009 | US20090017536 Modified vaccinia ankara virus variant and cultivation method |
| 01/15/2009 | US20090017523 Virus purification methods |
| 01/15/2009 | US20090017522 proteolytic fragment of a growth differentiation factor (GDF) polypeptide (pro-GDF) or a functional peptide portion thereof; affects activity associated with GDF signal transduction |
| 01/15/2009 | US20090017521 Chimaeric phages |
| 01/15/2009 | US20090017494 Tick octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 01/15/2009 | US20090017447 Human Endogenous Retrovirus with Foamy-Like Properties and Uses Thereof |
| 01/15/2009 | US20090017069 SARS Vaccine Compositions and Methods of Making and Using Them |
| 01/15/2009 | US20090017068 Vaccines against West Nile Virus |
| 01/15/2009 | CA2692744A1 Apparatus and method for harvesting biologics from eggs |
| 01/15/2009 | CA2690317A1 Replication deficient influenza virus for the expression of heterologous sequences |
| 01/14/2009 | EP1751289B1 Tc-83-derived alphavirus vectors, particles and methods |
| 01/14/2009 | EP1751276B1 Vaccine comprising an attenuated pestivirus |
| 01/14/2009 | EP1331270B1 Novel recombinant feline herpesvirus 1 and polyvalent vaccine with the use of the same |
| 01/14/2009 | EP1183049B1 Modification of biological elements |
| 01/14/2009 | EP1115877B1 Polynucleotide constructs and uses thereof |
| 01/14/2009 | CN101343640A Common expression CTLA4Ig and CTLA4 recombinant adenovirus carrier, recombinant adenovirus and uses thereof |
| 01/14/2009 | CN101343625A Virus purification methods |
| 01/14/2009 | CN101343624A Recombined human growth hormone gene bacilliform virus, preparation and application thereof |
| 01/14/2009 | CN101343315A Shorten human papilloma virus 6 type L1 protein |
| 01/14/2009 | CN101343314A Shorten human papilloma virus II type L1 protein |
| 01/14/2009 | CN100451109C Recombinant herpes simplex virus type 2 and its preparing method and use |
| 01/13/2009 | US7476728 Flea GABA receptor subunit nucleic acid molecules |
| 01/13/2009 | US7476389 Papillomavirus vaccines |
| 01/13/2009 | US7476382 Reovirus for the treatment of neoplasia |
| 01/13/2009 | CA2615372A1 Influenza virus-like particles (vlps) comprising hemagglutinin |
| 01/13/2009 | CA2233932C Vaccines against infections caused by yf virus; yf infectious cdna, method for producing a recombinant yf virus from the yf infectious cdna and plasmids to assemble the yf infectious cdna |
| 01/08/2009 | WO2009006618A2 Herpes simplex virus mutant icp0 protein |
| 01/08/2009 | WO2009006420A2 Vaccine production for pathogenic bird viral diseases |
| 01/08/2009 | WO2009006300A2 Production cell lines for adenoviral manufacturing |
| 01/08/2009 | WO2009005380A1 Method of obtaining bacteriophage preparation |
| 01/08/2009 | WO2009004641A2 Adaptation of pitman moore strain of rabies virus to primary chick embryo fibroblast cell cultures |
| 01/08/2009 | WO2008144700A3 Simian t-cell lymphotropic virus type 3 west african subtype d |
| 01/08/2009 | WO2008091659A3 Methods and compositions for predicting and treating drug resistant strains of influenza virus |
| 01/08/2009 | US20090012003 Polypeptides homologous to vegf and bmp1 |
| 01/08/2009 | US20090011494 Method for controlling biological function with mechanical vibration and device therefor |
| 01/08/2009 | US20090011485 Method of retrovirus storage |
| 01/08/2009 | US20090010962 Genetically Engineered Swine Influenza Virus and Uses Thereof |
| 01/08/2009 | US20090010961 Avirulent, immunogenic flavivirus chimeras |
| 01/08/2009 | US20090010960 Bacteriophage-mediated immunisation against hepatitis |
| 01/08/2009 | US20090010955 Vaccines Containing Canine Parvovirus Genetic Variants |
| 01/08/2009 | US20090010917 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 01/08/2009 | CA2692149A1 Vaccine production for pathogenic bird viral diseases |
| 01/08/2009 | CA2691868A1 Immortalized avian cell lines |
| 01/08/2009 | CA2691629A1 Adaptation of pitman moore strain of rabies virus to primary chick embryo fibroblast cell cultures |
| 01/07/2009 | EP2011862A1 Method for manufacturing an active component of a medicine or diagnosis agent in MDCJ cell suspension culture |
| 01/07/2009 | EP2011510A2 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments |
| 01/07/2009 | EP1644492B1 Modified recombinant vaccinia viruses, uses thereof |
| 01/07/2009 | EP1455840B1 Treatment of human soft tissue sarcoma with adenoviral vector expressing tnf-alpha |
| 01/07/2009 | EP1409684B1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/07/2009 | EP1407008B1 Influenza vaccine composition |
| 01/07/2009 | EP1317559B1 Dna transfection system for the generation of infectious negative strand rna virus |
| 01/07/2009 | EP1198581B1 Method for reducing the antigenicity of adeno-associated virus structural protein |
| 01/07/2009 | EP1147180B1 Propagation of bovine coronavirus in chinese hamster ovary cells |
| 01/07/2009 | CN101338303A Adenovirus marked by radionuclide |
| 01/07/2009 | CN101338302A Recombination herpes simplex virus for tumor gene therapy |
| 01/06/2009 | US7473773 Determination of hepatitis C virus genotype |
| 01/06/2009 | US7473772 Chimeric GB virus B (GBV-B) |
| 01/06/2009 | US7473536 To increase the titer of avipoxviruses produced from cells after infection of cells with the avipoxvirus, wherein the host range gene is expressed in cells |
| 01/06/2009 | US7473418 Pan cancer oncolytic vectors and methods of use thereof |
| 01/06/2009 | CA2380231C Conditionally controlled, attenuated hiv vaccine |
| 01/06/2009 | CA2108147C Heterodimeric receptor libraries using phagemids |
| 01/01/2009 | US20090005334 Nucleic acid derivatives |
| 01/01/2009 | US20090004743 Helper virus-free aav production |
| 01/01/2009 | US20090004733 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides, and uses thereof |
| 01/01/2009 | US20090004723 Methods and Compositions Concerning Poxviruses and Cancer |